Lucid Tala vs Otofonix Groove

The Lucid Tala is a premium OTC hearing aid priced at $1,300, earning an A grade with a SoundScore of 4.6/5 in our lab testing. This places it among the top performers in the OTC category, ranking #4 out of 65 tested devices. Speech performance stands out as the Tala's defining strength. Speech in quiet scores an excellent 4.6/5, measuring 1.85 points above the OTC category average. Speech in noise also performs well at 3.0/5, exceeding the category average by 1.56 points—a meaningful advantage for conversations in challenging environments. Music streaming delivers solid results at 3.0/5, outpacing the category average by 1.08 points. The Tala does show limitations in feedback handling, scoring 1.7/5 in our tuned testing—2.84 points below the category average. This is a notable weakness that prospective buyers should consider, particularly if prone to feedback-inducing situations. Own-voice comfort scores 2.6/5, which is above the category average but only mixed in absolute terms. This visible-in-ear style device features rechargeable batteries and supports streaming from both iPhone and Android devices with hands-free capability. The Tala has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. It's best suited for users who prioritize speech clarity and are willing to invest in a premium OTC option, though those particularly sensitive to feedback may want to explore alternatives.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.